Cited by 1,695Computational Drug Discovery MethodsArtificial Intelligence in Healthcare and EducationArtificial Intelligence Applications

Artificial intelligence in drug discovery and development

Open access
Paul, Debleena, Sanap, Gaurav, Shenoy, Snehal, Kalyane, Dnyaneshwar, Kalia, Kiran, Tekade, Rakesh K.·2021·Drug Discovery Today

Abstract

Artificial intelligence-integrated drug discovery and development has accelerated the growth of the pharmaceutical sector, leading to a revolutionary change in the pharma industry. Here, we discuss areas of integration, tools, and techniques utilized in enforcing AI, ongoing challenges, and ways to overcome them.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2020.10.010

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AI is used for monitoring clinical trials, and data gathering and analysis from them.

    “They are also used in monitoring clinical trials, and data gathering and analysis from them [30].”

    From A Review of Trustworthy and Explainable Artificial Intelligence (XAI) (2023) · cites this paper as [30]

    The 'AI in clinical trial design' section describes software monitoring medication intake during a Phase II trial. The 'AI in the lifecycle of pharmaceutical products' section says AI can manage generated clinical data, but our copy does not establish that AI gathers and analyzes data from clinical trials specifically. Page numbers are unavailable in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Errors by AI or the human involved in the creation of the AI could lead to loss of lives.

    “Any errors by AI or the human involved in the creation of the AI, could lead to loss of lives [30], [33], [34].”

    From A Review of Trustworthy and Explainable Artificial Intelligence (XAI) (2023) · cites this paper as [30]

    The ‘Ongoing challenges in adopting AI’ section discusses data quality, inaccurate predictions, and the need for human intervention, but does not say that AI or human errors could cause loss of life. A further search for fatal errors, patient deaths, and related harms found no passage addressing that consequence. No page numbers were available in our copy. (LLM, conf=0.75)

    Experimental — accuracy not yet measured
  • The use of AI in medicinal chemistry has gained significant attention in recent years as a potential means of revolutionizing the pharmaceutical industry.

    “The use of artificial intelligence (AI) in medicinal chemistry has gained significant attention in recent years as a potential means of revolutionizing the pharmaceutical industry [3].”
  • AI-based methods can accelerate the drug discovery process and enable the development of more effective medications.

    “Many more examples are available [3,32,33,34,35,36,37], showing that AI-based methods can accelerate the drug discovery process and enable the development of more effective medications.”
  • Integration of AI with traditional experimental methods can enhance the drug discovery process.

    “However, the integration of AI with traditional experimental methods can also enhance the drug discovery process [3].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [52]Basile A.O. Artificial intelligence for drug toxicity and safety Trends Pharmacol. Sci. 40 2019 624 635 31383376 PMC6710127

Cited by

Sorted by citations

Authors
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K.
Affiliations
Government of India (IN)
Corresponding author
Tekade, Rakesh K.
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2021-01
Volume
26
Issue
1
Pages
80-93
ISSN
1359-6446 (ISSN-L)
OpenAlex
W3094492244
Cited by
1,695
References
129
Citations by year
2026: 308 · 2025: 385 · 2024: 479 · 2023: 278 · 2022: 159 · 2021: 83 · 2020: 2
FWCI
11.61
Type
journal article
Language
en
Open access
Locations
  • Drug Discovery Today (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India
  • Science and Engineering Research Board
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Computer Science › Artificial Intelligence › Artificial Intelligence Applications
Keywords
artificial intelligence, drug discovery, drug development, pharmaceutical industry, AI adoption barriers
MeSH terms
Pharmaceutical Research, Artificial Intelligence, Humans, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review